These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8584548)

  • 1. Management of venous thromboembolic (VTE) disease--Part I: Prevention.
    Kayser SR
    Prog Cardiovasc Nurs; 1995; 10(4):31-6. PubMed ID: 8584548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk and prevention of venous thromboembolic complications in surgery].
    Baeshko AA
    Khirurgiia (Mosk); 2001; (4):61-9. PubMed ID: 11490498
    [No Abstract]   [Full Text] [Related]  

  • 3. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of thromboembolism.
    Geelhoed GW
    Am Fam Physician; 1979 Mar; 19(3):147-53. PubMed ID: 425867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 6. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 7. The Otto Aufranc Award paper. New advances in the prevention, diagnosis, and cost effectiveness of venous thromboembolic disease in patients with total hip replacement.
    Paiement GD; Bell D; Wessinger SJ; Harris WH
    Hip; 1987; ():94-119. PubMed ID: 3102409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboembolic risk].
    Campisi M; Stacca R; Tassi A; Laganà G; Piccinini P
    Minerva Anestesiol; 1988 Oct; 54(10):405-12. PubMed ID: 3255087
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis, prevention, and treatment of venous thromboembolism.
    Kakkar VV
    Int Anesthesiol Clin; 1985; 23(2):157-72. PubMed ID: 4008062
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombophlebitis and pulmonary embolism in the elderly patient.
    Kinasewitz GT
    Clin Chest Med; 1993 Sep; 14(3):523-36. PubMed ID: 8222567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 14. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European consensus statement on the prevention of venous thromboembolism. European Consensus Conference, Windsor, U.K., November, 1991.
    Haas S
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S5-8; discussion S9-10. PubMed ID: 8180330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discoveries in thrombosis care for medical patients.
    Cohen AT
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():13-7. PubMed ID: 12232818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].
    Stammler F; Diehm C
    Dtsch Med Wochenschr; 1998 May; 123(19):604-11. PubMed ID: 9618643
    [No Abstract]   [Full Text] [Related]  

  • 19. What's new in the prevention, diagnosis and treatment of venous thromboembolic disease.
    Jones JS
    J Miss State Med Assoc; 1997 Apr; 38(4):115-8. PubMed ID: 9114668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of sodium heparin as compared to calcium heparin for preventing thromboembolic complications].
    Segesser D; Gruber UF
    Arzneimittelforschung; 1977; 27(11):2157-63. PubMed ID: 580021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.